NEWS IN BRIEF

Ardena: M&A growth fuels HQ expansion

By Flora Southey contact

- Last updated on GMT

Ardena HQ, Belgium
Ardena HQ, Belgium

Related tags: CDMO, Belgium

CDMO Ardena has moved into larger headquarters in Gent, Belgium, to “free up space for additional laboratories”, says CEO.

According to the contract development and manufacturing organisation (CDMO), a sustained period of growth, driven by mergers and acquisitions, prompted the move.

“After several acquisitions and an ongoing growth period, we are firmly on track to reach our €35m ($39.7m) sales target for 2018 ​as part of our wider strategy to become a leading integrated drug development company,”​ said CEO Harry Christiaens.

Ardena was formed in 2017, as the result of a merger between Pharmavize, Crystallics and Analytical Biochemical Laboratory (ABL).

The CDMO has since integrated active pharmaceutical ingredient (API) and nanomedicine maker, ChemConnection​, as well as API and excipient-focused Syntagon​ into its business.

Christiaens continued: “This new, larger headquarters will enable us to free up space for additional laboratories at our other sites and further expand our capabilities.

“It will also provide a base for our staff training centre to ensure we develop our team.”

Related news

Show more

Related products

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Follow us

Products

View more

Webinars